0 results found with selected filters. Please refine the filters. Redirecting to initial search..
Table "column sort" updates the order of the bars in the chart.
downloaded on: 2023/03/21 02:17:54
Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Formula |
Value |
Units |
SEM |
SD |
Individual Records |
Method |
Method Duration |
Post Insult Time Value |
Experiment Notes |
Record ID |
Study ID |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
72.41 |
% |
4.51 |
13.52 |
M041FHBN17: 53.352
M038FHBN17: 54.167
M039FHBN17: 59.453
M031FHBN17: 72.216
M042FHBN17: 76.863
M029FHBN17: 78.768
M033FHBN17: 82.943
M030FHBN17: 85.615
M040FHBN17: 88.278
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46112 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
73.52 |
% |
6.79 |
17.95 |
F036FHBN17: 48.164
F043FHBN17: 62.5
F045FHBN17: 64.757
F046FHBN17: 66.631
F048FHBN17: 83.313
F044FHBN17: 89.282
F047FHBN17: 100.0
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46114 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
53.38 |
% |
3.75 |
15.47 |
M194FHBN17: 26.167
M201FHBN17: 29.767
M196FHBN17: 34.662
M199FHBN17: 37.488
M192FHBN17: 45.161
M195FHBN17: 47.661
M087FHBN17: 47.857
M193FHBN17: 51.429
M086FHBN17: 52.688
M078FHBN17: 58.7
M089FHBN17: 60.036
M186FHBN17: 60.348
M079FHBN17: 67.359
M076FHBN17: 67.473
M082FHBN17: 68.734
M088FHBN17: 73.033
M077FHBN17: 78.968
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47123 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
16 |
post-ischemic value/pre-ischemic value x 100% |
52.79 |
% |
4.3 |
17.2 |
F187FHBN17: 28.136
F188FHBN17: 30.295
F189FHBN17: 33.304
F190FHBN17: 37.308
F198FHBN17: 42.835
F203FHBN17: 45.359
F204FHBN17: 45.744
F191FHBN17: 48.152
F202FHBN17: 48.425
F081FHBN17: 58.283
F074FHBN17: 61.2
F090FHBN17: 61.24
F091FHBN17: 69.99
F075FHBN17: 71.38
F080FHBN17: 81.095
F083FHBN17: 81.863
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47125 |
461 |
|